Edition:
United States

Rocket Pharmaceuticals Inc (RCKT.OQ)

RCKT.OQ on NASDAQ Stock Exchange Global Market

24.77USD
24 Sep 2018
Change (% chg)

$1.41 (+6.04%)
Prev Close
$23.36
Open
$23.42
Day's High
$25.08
Day's Low
$23.42
Volume
102,195
Avg. Vol
106,110
52-wk High
$25.84
52-wk Low
$6.12

Select another date:

Fri, May 18 2018

BRIEF-Rocket Pharmaceuticals Presents Updated Data From Phase 1/2 Gene Therapy Trial Of Rp-L102

* ROCKET PHARMACEUTICALS PRESENTS UPDATED DATA FROM PHASE 1/2 GENE THERAPY TRIAL OF RP-L102 IN PATIENTS WITH FANCONI ANEMIA AT THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) ANNUAL MEETING

BRIEF-Rocket Pharmaceuticals Announces Strategic Research Collaboration

* ROCKET PHARMACEUTICALS ANNOUNCES STRATEGIC RESEARCH COLLABORATION

BRIEF-Rocket Pharma Appoints Former FDA Staffer As VP Of Regulatory Policy And Patient Advocacy

* ROCKET PHARMACEUTICALS APPOINTS GAYATRI R. RAO, M.D., J.D., FORMER U.S. FOOD AND DRUG ADMINISTRATION DIRECTOR OF THE OFFICE OF ORPHAN PRODUCTS DEVELOPMENT, AS VICE PRESIDENT, REGULATORY POLICY AND PATIENT ADVOCACY Source text for Eikon: Further company coverage:

BRIEF-Rocket Pharmaceuticals Reports Q1 Loss Per Share Of $0.42

* ROCKET PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Rocket-control glitch delays launch of NASA's planet-hunting satellite

CAPE CANAVERAL, Fla. An 11th-hour technical glitch prompted SpaceX to postpone its planned launch on Monday of a new NASA space telescope designed to detect worlds beyond our solar system, delaying for at least 48 hours a quest to expand astronomers' known inventory of so-called exoplanets.

Select another date: